Gastroenterology

Gastroenterology

Volume 112, Issue 1, January 1997, Pages 118-126
Gastroenterology

Glutamine depletion and increased gut permeability in nonanorectic, non-weight-losing tumor-bearing rats

https://doi.org/10.1016/S0016-5085(97)70226-9Get rights and content

Abstract

BACKGROUND & AIMS: Glutamine is an essential amino acid for rapidly dividing cells such as enterocytes. The progress of cancer is associated with a decrease of arterial and muscle glutamine concentrations. The aim of this study was to test whether increasing tumor loads affect gut intracellular glutamine handling, protein turnover, and gut absorptive and barrier function. METHODS: Methylcholantrene-induced tumor-bearing rats were studied with a subcutaneous tumor load of 5%-15% or 15%-30% of body weight. Portal drained visceral net uptake or release of energy substrates, amino acids, and intestinal protein turnover were studied. Gut absorptive capacity and permeability was assessed by the urinary recovery of 3-O- methyl-D-glucose or lactulose-rhamnose ratio after an oral gavage. RESULTS: In tumor-bearing rats, the net uptake of energy substrates (ketones and glutamine) and net protein synthesis increased across the portal drained viscera, whereas mucosal glutamine concentrations decreased. Absorptive capacity remained unchanged in both tumor-bearing groups. However, the lactulose-rhamnose ratio increased with increasing tumor load, indicating loss of gut barrier function. This was not related to changes in villus height, crypt depth, or changes in mucosal cell populations but to decreased intracellular polyamine concentrations. CONCLUSIONS: The presence of a methylcholantrene tumor leads to altered mucosal glutamine metabolism and loss of gut barrier function possibly related to disturbed proliferation or differentiation of enterocytes. (Gastroenterology 1997 Jan;112(1):118-26)

References (0)

Cited by (38)

  • Oral glutamine supplementation during preoperative radiochemotherapy in patients with rectal cancer: A randomised double blinded, placebo controlled pilot study

    2011, Clinical Nutrition
    Citation Excerpt :

    They concluded that glutamine deficiency didn’t affect tumour growth but it contributed to the development of impaired physiological functions such as disturbed mucosal integrity and diminished immune competence.7 Studies on transport of amino acids between organs in animals with cancer also suggested that presence of cancer induces gut dysfunction and increases glutamine disposal, leading to disturbances in the integrity of the gut.8–10 In addition, exposure of abdominal region to ionizing radiation during radiotherapy in itself causes mucosal damage, intestinal inflammation and dysfunction.11

  • The 2007 ESPEN Sir David Cuthbertson Lecture: Amino acids between and within organs. The glutamate-glutamine-citrulline-arginine pathway

    2008, Clinical Nutrition
    Citation Excerpt :

    We showed that compromised gut protein synthesis during isoleucine-free protein diets (“blood meals”) could be restored by intravenous isoleucine infusion.9 After this initial period, our research focused more on glutamine metabolism and glutamine-rich nutritional support.10–13 Furthermore, we expanded our research towards arginine (and related citrulline) metabolism and arginine-rich nutritional support,14–16 and examined the potentials of arginine supplementation in patients with sepsis.17

View all citing articles on Scopus
View full text